Sample size in multistakeholder Delphi surveys: at what minimum sample size do replicability of results stabilize?Anthony Muchai Manyara, Anthony Purvis, Oriana Ciani et al.|Journal of Clinical Epidemiology|2024Cited by 134
A framework for the definition and interpretation of the use of surrogate endpoints in interventional trialsOriana Ciani, Rod S Taylor, Anthony Muchai Manyara et al.|EClinicalMedicine|2023Cited by 60
Reporting of surrogate endpoints in randomised controlled trial reports (CONSORT-Surrogate): extension checklist with explanation and elaborationAnthony Muchai Manyara, Oriana Ciani, John H. Powers et al.|BMJ|2024Cited by 45
Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping reviewAnthony Muchai Manyara, Oriana Ciani, Philippa Davies et al.|Journal of Clinical Epidemiology|2023Cited by 30
Surrogate endpoints: a key concept in clinical epidemiologyRobin Christensen, Rod S Taylor, Oriana Ciani et al.|Journal of Clinical Epidemiology|2023Cited by 29